SPHDF: Santhera Pharmaceuticals Holding AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 147.37
Enterprise Value ($M) n/a
Book Value ($M) 27.70
Book Value / Share 2.20
Price / Book n/a
NCAV ($M) -48.98
NCAV / Share -3.89
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.87

Liquidity (mrq)
Quick Ratio 1.26
Current Ratio 1.64

Balance Sheet (mrq) ($M)
Current Assets 75.81
Assets 152.49
Liabilities 124.79
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 39.12
Operating Income -33.15
Net Income -41.97

Cash Flow Statement (mra) ($M)
Cash From Operations -35.53
Cash from Investing -0.06
Cash from Financing 46.08

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
SNNC – Sibannac, Inc. SNPHF – Santen Pharmaceutical Co., Ltd.
SNYNF – Sanofi SPRB – Spruce Biosciences, Inc.
SQZB – SQZ Biotechnologies Company


Financial data and stock pages provided by
Fintel.io